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Abstract: The term ‘emphysema’ is generally used in a morphological sense, and therefore 
imaging modalities have an important role in diagnosing this disease. In particular, high 
resolution computed tomography (HRCT) is a reliable tool for demonstrating the pathology 
of emphysema, even in subtle changes within secondary pulmonary lobules. Generally, pul-
monary emphysema is classiﬁ  ed into three types related to the lobular anatomy: centrilobular 
emphysema, panlobular emphysema, and paraseptal emphysema. In this pictorial review, we 
discuss the radiological – pathological correlation in each type of pulmonary emphysema. 
HRCT of early centrilobular emphysema shows an evenly distributed centrilobular tiny areas 
of low attenuation with ill-deﬁ  ned borders. With enlargement of the dilated airspace, the sur-
rounding lung parenchyma is compressed, which enables observation of a clear border between 
the emphysematous area and the normal lung. Because the disease progresses from the centri-
lobular portion, normal lung parenchyma in the perilobular portion tends to be preserved, even 
in a case of far-advanced pulmonary emphysema. In panlobular emphysema, HRCT shows 
either panlobular low attenuation or ill-deﬁ  ned diffuse low attenuation of the lung. Paraseptal 
emphysema is characterized by subpleural well-deﬁ  ned cystic spaces. Recent topics related to 
imaging of pulmonary emphysema will also be discussed, including morphometry of the airway 
in cases of chronic obstructive pulmonary disease, combined pulmonary ﬁ  brosis and pulmonary 
emphysema, and bronchogenic carcinoma associated with bullous lung disease.
Keywords: pulmonary emphysema, HRCT, radiologic-pathologic correlation, pulmonary 
ﬁ  brosis, bronchus, lung cancer
Introduction
Chronic obstructive pulmonary disease (COPD) is a disease characterized by airﬂ  ow 
limitation that is not fully reversible (Pauwels et al 2001). The pathogenesis of COPD 
is thought to be chronic inﬂ  ammation throughout the airways, parenchyma, and pul-
monary vasculature (Pauwels et al 2001). Pathologic changes characteristic of COPD 
occur in all these respiratory structures. Among these changes, destruction of the 
lung parenchyma is commonly referred to as pulmonary emphysema, deﬁ  ned as “an 
abnormal permanent enlargement of the air space distal to the terminal bronchioles, 
accompanied by destruction of the alveolar walls, and without obvious ﬁ  brosis” (ATS 
1962; Snider et al 1985). The etiology of pulmonary emphysema has not been fully 
established (Tuder et al 2006), but the prevailing concept is that lung inﬂ  ammation 
caused by cigarette smoke, environmental pollutants, or bacterial products leads to an 
imbalance of proteases and antiproteases (Tuder et al 2006). Although the traditional 
inﬂ  ammatory cell implicated in emphysema is the neutrophil which releases neutoro-
phil elastase, recent research has been focused on the macrophage and macrophage-
derived protease (Wright and Churg 2007). The link between the inﬂ  ammation and 
inﬂ  ammation-related genes was also highlighted (Grumelli et al 2004). Apoptosis and 
oxidative stress also act as ampliﬁ  cation mechanisms (Tuder et al 2006).
The term emphysema is generally used in a morphological sense in the ﬁ  eld 
of pathology and radiology and should not be directly related with physiological 
impairment. Imaging modalities have an important role in diagnosis of pulmonary International Journal of COPD 2008:3(2) 194
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emphysema, and high resolution computed tomography 
(HRCT) is an especially reliable tool for demonstrating the 
pathology of emphysema, even for subtle changes in second-
ary pulmonary lobules. In this pictorial review, we show 
the radiological – pathological correlation in pulmonary 
emphysema. Recent topics related to imaging of pulmonary 
emphysema will also be discussed, including morphometry of 
the airway in cases of COPD, combined pulmonary ﬁ  brosis 
and pulmonary emphysema, and bronchogenic carcinoma 
associated with bullous lung disease (BLD).
Anatomy of the secondary 
pulmonary lobule
An understanding of the normal anatomy of the peripheral 
lung is required when interpreting CT images of pulmonary 
emphysema. From the trachea, airways with a diameter of 
1 mm reach the level of the lobular bronchus after 9 to 14 
dichotomous branches. Lobular bronchus has 3 to 5 smaller 
airways, which are called terminal bronchioles (Figure 1). 
These bronchioles arise at intervals of 1 to 2 mm while pre-
lobular bronchi arise at intervals of 0.5 to 1.0 cm (Reid 1958). 
A unit consisting of 3 to 5 terminal bronchioles supplied by a 
small bronchus with a diameter of 1 mm is called a secondary 
pulmonary lobule (Reid’s lobule) (Reid 1958). Therefore, an 
intralobular region can be recognized if the branching distance 
Figure 1 Secondary pulmonary lobule: Reid’s deﬁ  nition. Contact radiograph of the 
inﬂ  ated ﬁ  xed lung specimen showing the branching terminal bronchioles (arrows). These 
terminal bronchioles arise at intervals of 1 to 2 mm.   The bar represents 5 mm.
Abbreviations: BR, bronchus; PA, pulmonary artery; PV, pulmonary vein; ILS, 
interlobular septum.
Figure 3 Secondary pulmonary lobule: Miller’s deﬁ  nition. Specimen photograph 
demonstrating a rich network of interlobular septa. Noted that the area surrounded 
by the septa is variable.
Abbreviation: PV, pulmonary vein.
Figure 2 The cm and mm patterns. Diagram (modiﬁ  ed from Reid) showing the 
branching pattern of the end of a bronchial pathway. Initially the branches arise 
at intervals of approximately 0.5 to 1.0 cm (A to B) and then arise at intervals of 
approximately 2 mm (beyond B). Copyright © 1958. Adapted and reproduced with 
permission from the BMJ Publishing Group, from Reid L.1958. The secondary lobule 
in the adult human lung with special reference to its appearance in bronchograms. 
Thorax, 13:110–15.
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is constant at 1 to 2 mm. Prelobular branching is referred to 
as a “cm pattern” and an intralobular pattern is called an “mm 
pattern” (Reid 1958) (Figure 2), and the area supplied by 
each terminal bronchiole is called an “acinus”. Miller (1950) 
deﬁ  ned the secondary lobule as an area surrounded by the 
interlobular septum (Figure 3). Reid’s and Miller’s lobules are 
not conceptually the same, because the interlobular septum is 
not constantly and uniformly observed within the lung, and 
the area surrounded by the septum ranges from 1 to 3 cm; in 
contrast, Reid’s lobule is constantly and uniformly observed 
throughout the lung (Itoh et al 1993).
Terminal bronchioles branch off respiratory bronchi-
oles which have walls with pores of alveoli. After 2 to 3 
branches of respiratory bronchioles, the number of alveolar 
fenestrations increases gradually and these then change into 
alveolar ducts and sacs (Figure 4). The airway is essentially 
accompanied by the pulmonary artery, even at the level of 
secondary pulmonary lobules. The area around the terminal 
bronchiole and the 1st ordered respiratory bronchiole is 
called the “centrilobular portion” or “centriacinar portion” 
(Spencer 1985) (Figure 5). The pulmonary vein runs between 
the pulmonary segment and connects to the interlobular 
septum, which forms peripheral connective tissue together 
with the visceral pleura. The distance from the centrilobular 
portion to the peripheral structure, including the interlobular 
septum, pulmonary vein and pleura, is constant at about 2.5 
mm (Itoh et al 1978; Murata et al 1986).
Visualization of peripheral lung 
structure by HRCT
In general, HRCT can be used to visualize an airway with 
a diameter larger than 2 mm, which corresponds to sub-
subsegmental bronchi (Murata et al 1986). These bronchi 
are generally located in the inner two-thirds of the lung ﬁ  eld 
(Murata et al 1986). In the distal lung ﬁ  eld, the course of the 
airway can be recognized from the branching structure of 
the pulmonary artery that accompanies the airway. CT shows 
the pulmonary artery down to a caliber of 200 μm (Murata 
et al 1986). This portion corresponds to the level of the tip of 
the terminal bronchioles and the 1st respiratory bronchioles 
(Itoh et al 1978, Murata et al 1986). Therefore, a centrilobular 
region can be recognized as an area around the tip of the visible 
pulmonary artery (Figures 6, 7). Centrilobular abnormalities 
always have a distance of about 2.5 mm from the perilobular 
structure, including interlobular septum, pleura and large 
pulmonary vessels (Murata et al 1986, 1989). Recent HRCT 
with thinner collimation (0.5–1.0 mm) has more powerful 
Figure 4 Terminal and respiratory bronchioles. Specimen photograph demonstrating 
ramiﬁ  cation of the two 1st respiratory bronchioles (1RB) from the terminal bronchiole 
(TB). The respiratory bronchiole wall has alveolar pores.   After branching of the 
respiratory bronchiole 2 to 3 times (2RB, 3RB), the number of alveolar fenestrations 
increases gradually and these eventually change into the alveolar duct and then the 
alveolar sac.
Figure 5 Centrilobular areas. Diagram showing the centrilobular areas, which 
correspond to the areas around the tips of terminal bronchioles and 1st respiratory 
bronchioles. Copyright © 1989. Modiﬁ  ed with permission from Murata K, Khan A, 
Herman PG. 1989. Pulmonary parenchymal disease: evaluation with high-resolution 
CT. Radiology, 170:629–35.International Journal of COPD 2008:3(2) 196
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resolution for demonstration of peripheral lung structures, in 
which the distance between the most distal visible pulmonary 
artery and pleura is about 1–1.5 mm and that between the most 
distal visible airway and pleura is about 1.5 cm. The former 
corresponds to the level of 2nd respiratory bronchioles and the 
latter to prelobular bronchi (Takahashi et al 2002).
Classiﬁ  cation of pulmonary 
emphysema
Pulmonary emphysema can be classiﬁ  ed into three major 
subtypes based on the disease distribution within secondary 
pulmonary lobules (Stern and Frank 1994; Thurlbeck and Müller 
1994): centriacinar emphysema, panacinar emphysema, and dis-
tal acinar emphysema (Figure 8). The relationships among these 
types of pulmonary emphysema and how each type is formed 
have yet to be clariﬁ  ed. The subtypes of emphysema can usually 
be determined in mild or moderate cases, but classiﬁ  cation into 
anatomic subtypes becomes more difﬁ  cult by CT and pathology 
as emphysema becomes more severe, with even highly trained 
and experienced pathologists sometimes disagreeing on the 
classiﬁ  cation (Mitchell et al 1970). Centriacinar and panacinar 
emphysema can also coexist in the same patient; for example, 
with centriacinar emphysema in the upper lobe and panacinar 
emphysema in the lower lobe (Mitchell et al 1970).
Centriacinar emphysema
Centriacinar emphysema is the commonest type of pulmo-
nary emphysema and is characterized by an enlargement of 
the centriacinar airspace, with the effect mainly occurring in 
proximal respiratory bronchioles, leaving normal distal alveo-
lar ducts and sacs (Leopold and Gough 1957). The disease 
mainly involves the second and third respiratory bronchi-
oles, and the severity of destruction of the lung parenchyma 
usually differs from lobule to lobule (Leopold and Gough 
1957). Development of centriacinar emphysema is believed 
to be closely related to cigarette smoking and dust inhalation 
(ATS 1962; Finkelstein et al 1995; Cosio Piqueras et al 2001; 
Pauwels et al 2001; Satoh et al 2001), and most emphysema 
observed in heavy smokers is centriacinar emphysema 
(Thurlbeck 1963). The disease is usually distributed to the 
upper lobe or the superior segment of the lower lobe (Figure 
9). The precise reasons for this distribution are unclear, but 
may include regional differences in perfusion, transit time of 
leukocytes, clearance of deposited dust, and pleural pressure 
(Gurney 1991). The inner zone is more severely affected than 
the outer zone, which may be explained by zonal differences 
in respiratory kinetics and lymph ﬂ  ow (Nakano et al 1999).
The characteristic appearance of a gross specimen of cen-
triacinar emphysema is pigmentation (anthracosis) in a patchy 
Figure 6 Structures of the peripheral lung that can be observed with HRCT. Right side: 
structure of the secondary lobule. Left side: structures visible on HRCT. Intralobular 
bronchioles cannot be seen. The smallest intralobular arteries that can be seen on 
HRCT are approximately 0.2 mm in diameter, which corresponds to the level of the 
tip of the terminal bronchiole and the 1st respiratory bronchiole. Therefore, the 
centrilobular portion can be seen as an area around the tip of the visible pulmonary 
artery on HRCT. Intralobular (interacinar) venules cannot be observed.
Abbreviations: BR, bronchus; HRCT, high resolution computed tomography; PA, 
pulmonary artery; PV, pulmonary vein; pv, intralobular (interacinar) venule; ILS, 
interlobular septum.
Figure 7 HRCT of the normal lung. The pulmonary artery supplies two secondary 
lobules, and arrows indicate branching of the intralobular pulmonary arteries. The 
corresponding airways cannot be seen.
Abbreviations: HRCT, high resolution computed tomography; PA, pulmonary 
artery, PV, pulmonary vein.International Journal of COPD 2008:3(2) 197
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fashion in the inner zone of the lung (Figure 10). This is one 
of the clues shows that centriacinar emphysema is closely 
associated with inhaled exogenous dust. The pigmented area 
corresponds to centriacinar dilatation of the airspace, but 
this area is not a simple unilocular space and is composed of 
aggregated and dilated small air spaces (Figures 11, 12). The 
surrounding lung parenchyma shows a normal appearance, but 
there is no border structure between these regions. Therefore, 
HRCT in early centriacinar emphysema shows evenly distrib-
uted centrilobular tiny areas of low attenuation with ill-deﬁ  ned 
borders (Naidich et al 1982) (Figure 13). Aggregation of the 
dilated small airspaces is observed as a single air space since 
this feature is beyond the spatial resolution of CT. With enlarge-
ment of the dilated airspace, the surrounding lung parenchyma 
is compressed, which enables a clear border to be observed 
between the emphysematous area and normal lung (Naidich 
et al 1982) (Figures 14, 15). Since the disease progresses from 
the centrilobular portion, the normal lung parenchyma in the 
perilobular portion tends to be preserved, even in advanced 
Centrilobular(acinar) emphysema
Panlobular(acinar) emphysema
Paraseptal emphysema
Figure 8 Subtypes of pulmonary emphysema.
Figure 9 Distribution of centriacinar emphysema. Photograph of an inﬂ  ated and ﬁ  xed 
lung showing emphysematous foci with anthracosis mainly distributed in the upper 
lobe and superior segment of the lower lobe (*).
Figure 10 Distribution of centriacinar emphysema. Photograph of an inﬂ  ated and 
ﬁ  xed lung showing emphysematous foci with anthracosis mainly observed in the 
inner zone of the lung.International Journal of COPD 2008:3(2) 198
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Figure 11 Centriacinar emphysema. Magniﬁ  ed photograph of emphysematous foci 
showing aggregation of an enlarged airspace with anthracosis.  There is no bordering 
structure between the emphysematous space and surrounding lung parenchyma.
Figure 12 Centriacinar emphysema. Contact radiograph of an inﬂ  ated ﬁ  xed lung 
demonstrating low attenuation in the centriacinar area (arrow).  Note that distances 
between the centriacinar portions and perilobular portions are constant at 2.5 mm. 
The bar indicates 5 mm.
Abbreviation: ILS: interlobular septum.
Figure 13 Early stage of centriacinar emphysema. High resolution computed tomog-
raphy demonstrating numerous tiny low attenuation areas (LAAs) throughout the lung 
ﬁ  eld.  Note that each LAA does not have a clear wall.
Figure 14 Moderately progressed centriacinar emphysema. Photograph of an inﬂ  ated 
and ﬁ  xed lung demonstrating that the surrounding lung parenchyma is compressed 
with enlargement of the dilated air spaces, producing a clear border of the emphy-
sematous space (arrows).
pulmonary emphysema (Figure 16). It is not uncommon for 
the lung parenchyma to be subtly preserved near the large 
airway and vessel in a case of severe emphysema, which indi-
cates that the disease originated from the centrilobular portion 
(Figure 17). To understand the disease distribution, it is impor-
tant to recognize the borders of the large airway and vessel as 
perilobular structures. The caliber of the vessel in the involved 
area decreases, which may be attributable to redistribution of 
pulmonary blood ﬂ  ow to the uninvolved area.
It is a controversial issue whether ﬁ  brosis is present 
in the histology of pulmonary emphysema, although the 
deﬁ  nition of the National Heart, Lung and Blood Institute 
notes the absence of obvious ﬁ  brosis (Cardoso et al 1993; 
Lang et al 1994). Most pulmonary pathologists notice that International Journal of COPD 2008:3(2) 199
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the alveoli, resulting in evenly distributed emphysematous 
changes within secondary lobules (acini) (Thurlbeck 1995). 
In a gross specimen of a normal lung, the lumen of the alveo-
lar ducts and respiratory bronchioles are slightly larger than 
surrounding normal alveoli (Heppleston and Leopold 1961; 
Thurlbeck 1963). In very early panacinar emphysema, this 
contrast tends to diminish with an increase in the size of the 
alveolar space and a “monotonous” appearance is apparent 
(Thurlbeck 1995). Alpha 1-antitrypsin deﬁ  ciency is thought 
to be a major cause of panacinar emphysema, but the inci-
dence is very low (Eriksson 1965). Other etiologies, including 
Swyer-James syndrome (Swyer and James 1953; Macleod 
1954) and ritalin abuse, have been reported (Stern et al 1994), 
but most cases observed in surgical or autopsy specimens 
are unrelated to these conditions. Features that distinguish 
panacinar emphysema from centriacinar emphysema are 
as follows: the disease is dominant in the lower lung ﬁ  eld, 
whereas the upper lung is mainly affected in centriacinar 
emphysema (Thurlbeck 1963); the degree of lung inﬂ  ation 
is greater than that in centriacinar emphysema; there is a 
tendency for the airway to be narrowed; and bullous forma-
tion is less frequently observed compared to centriacinar 
emphysema (Mitchell et al 1970).
Two types of disease distribution have been recognized 
in panacinar emphysema: a localized form and a diffuse form 
(Thurlbeck 1995) (Figure 18). The former has a multilobular 
distribution and the latter has a distribution that is not related 
to the zonal anatomy of the lung. The striking difference from 
Figure 15 Moderately progressed centriacinar emphysema. On high resolution 
computed tomography, a “wall” structure is observed at the periphery of the emphy-
sema (arrows), composed of compressed lung tissue and perilobular vessels.
Figure 16 Advanced centriacinar emphysema. Photograph of an inﬂ  ated and ﬁ  xed lung 
showing that residual normal lung is clearly observed around the large vessels (arrows), 
even in progressed emphysema.  The long arrows represent pulmonary veins.
Figure 17   Advanced centriacinar emphysema. It is very difﬁ  cult to assess the sub-
type of emphysema using high resolution computed tomography. However, a small 
area of preserved normal lung can be observed around the large bronchovascular 
bundle and pulmonary vein, which indicates that this emphysema originated from the 
centriacinar area (arrow).
some degree of ﬁ  brosis is found around the emphysematous 
region (Cardoso et al 1993; Lang et al 1994), but how these 
ﬁ  brotic changes are reﬂ  ected on HRCT images of pulmonary 
emphysema is unknown (Tonelli et al 1997).
Panacinar emphysema
Panacinar emphysema is characterized by a uniform dila-
tation of the air space from the respiratory bronchioles to International Journal of COPD 2008:3(2) 200
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centriacinar emphysema is the low contrast to the neighbor-
ing normal lung (Stern and Frank 1994). The low attenuation 
of centriacinar emphysema is easily recognized on HRCT 
because of the contrast between the emphysematous region 
and the normal lung, whereas panacinar emphysema does 
not show a difference in intralobular attenuation because the 
entire lobule is involved to almost the same extent. Yamagishi 
and colleagues (1991) reported several CT-pathological 
observations in cases of panacinar emphysema, as follows: 
the low attenuation region is not evenly distributed within 
the lobule or lobule-by-lobule on HRCT, which is attrib-
uted to an uneven distribution of the degree of the disease; 
the caliber of the vessels in the involved area is decreased 
due to overinﬂ  ation of the air space; the localized form of 
panacinar emphysema has a polygonal border, which repre-
sents the interlobular septum, and perilobular large vessels 
are observed at the border of the lesion (Figure 19); and the 
margin of the diffuse form of panacinar emphysema is ill 
deﬁ  ned, due to the inhomogeneity of the intralobular disease 
distribution in lobules located at the periphery of the lesion 
(Figures 20, 21).
Distal acinar or paraseptal emphysema
Distal acinar or paraseptal emphysema is characterized as 
an enlarged airspace at the periphery of acini (Thurlbeck 
1995). The lesion is usually limited in extent, occurs most 
commonly along the dorsal surface of the upper lung 
(Figures 22, 23), and is often associated with ﬁ  brosis and 
may coexist with other types of emphysema. The patient is 
usually asymptomatic, but the condition is considered to be 
a cause of pneumothorax in young adults (Peters et al 1978; 
Lesur et al 1990).
Figure 18 Panacinar emphysema. An inﬂ  ated-ﬁ  xed lung does not demonstrate obvious 
anthracosis.  Enlargements of airspaces are diffusely observed and in some areas the 
disease is bordered by the interlobular septum (arrow).
Figure 19 Panacinar emphysema. On the photograph of an inﬂ  ated-ﬁ  xed lung, airspaces 
are evenly enlarged throughout the secondary lobule, but the degree of enlargement 
is not necessarily the same within the lobule.
Figure 20 Panacinar emphysema. On high resolution computed tomography, diffuse 
low attenuation changes are observed throughout the lung ﬁ  eld. A localized LAA is 
not apparent.
Aging lung
The lung undergoes a set of morphological and functional 
changes with aging. These changes, which may also be the 
result of environmental pollutants rather than aging alone 
(Thurlbeck 1995), include dilatation of alveolar ducts and 
respiratory bronchioles without obvious destruction of the 
alveolar wall (Ryan et al 1965). This is not referred to as 
emphysema, since emphysema is deﬁ  ned as an abnormal International Journal of COPD 2008:3(2) 201
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enlargement of the air space accompanied by destruction of 
the alveolar walls. In contrast to dilatation of alveolar ducts 
and respiratory bronchioles, the size of the alveoli is reduced, 
a process that has been referred to as “ductectasia” (Ryan 
et al 1965) (Figures 24, 25). This aging change is reﬂ  ected 
in the “rounds out” conﬁ  guration of the lung in which the 
anteroposterior diameter is increased (Anderson et al 1964). 
HRCT ﬁ  ndings of the aging lung have not been established, 
probably because the difference in attenuation accompanying 
the changes is small.
Imaging topics related 
to pulmonary emphysema
Phenotyping of COPD and imaging
COPD is considered to be a chronic inﬂ  ammatory process 
throughout the airway and lung parenchyme, allowing 
deﬁ  nition of two phenotypes involving primarily parenchymal 
disease (emphysema) and primarily airway disease (Nakano 
et al 2002; Hoffman et al 2006). These two pathologies 
frequently coexist in a diseased lung. Pathological changes 
of the large airway include enlarged mucus-secreting glands 
Figure 21 Panacinar emphysema in a case with bronchogenic carcinoma.
a. Preoperative CT showing a diffuse low attenuation area in the left upper lobe. The 
lung tumor is also observed in the dorsal portion of the left upper lobe (asterisks).
b. Contact photograph of the resected specimen. Panacinar emphysema is diffusely 
observed, but the dorsal area has a normal appearance.  There is no clear border 
between these regions and the change is gradual (bar). The caliber of the pulmonary 
artery in the involved area is markedly narrowed (large arrow) compared to that in 
normal lung (small arrow).
Figure 22 Distal acinar emphysema. Photograph of an inﬂ  ated and ﬁ  xed lung specimen 
showing subpleural airspaces with smooth wall structures.
Figure 23 Distal acinar emphysema. High resolution computed tomography showing 
subpleural airspaces (arrows) and associated centrilobular emphysema.
Figure 24 Aging lung. Contact radiograph of an inﬂ  ated and ﬁ  xed lung specimen 
showing a homogenous distribution of enlarged airspaces.International Journal of COPD 2008:3(2) 202
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and an increase in the number of goblet cells with mucus 
hypersecretion (Pauwels et al 2001). In the peripheral 
airways, chronic inﬂ  ammation leads to repeated cycles of 
injury and repair of the airway wall (Pauwels et al 2001), 
and the repair process results in structural remodeling of the 
airway wall (Pauwels et al 2001). Quantitative measurement 
of the airway by HRCT is a promising method for evalua-
tion of the inﬂ  ammatory condition of the airway in COPD, 
and recent studies have shown that HRCT can be used to 
divide COPD patients into groups with predominant lower 
lung attenuation or thickening and narrowing of the airway, 
although many subjects have both abnormalities (Nakano 
et al 2002 Hoffman et al 2006) (Figure 26).
Combined pulmonary ﬁ  brosis 
and pulmonary emphysema
Although not completely established, some patients with 
pulmonary emphysema in the upper lung ﬁ  eld are reported 
to have simultaneous pulmonary
 ﬁ  brosis in the lower lung ﬁ  eld (Wiggins et al 1990; Cot-
tin et al 2005; Lundblad et al 2005; Grubstein et al 2005; 
Mura et al 2006) (Figure 27). Cottin and colleagues (2005) 
performed a retrospective analysis of 61 patients with 
emphysema of the upper zones and diffuse parenchymal 
lung disease with ﬁ  brosis of the lower zones of the lung on 
chest CT. These patients were characterized by subnormal 
spirometry, severe impairment of gas exchange, a high preva-
lence of pulmonary hypertension, and poor survival. The 
patients were almost exclusively male and all were current 
or ex-smokers. The pathophysiology of combined pulmonary 
ﬁ  brosis and pulmonary emphysema (CPFE) is unknown, 
but it is speculated that both emphysema and ﬁ  brosis may 
be related to a common environmental trigger or a genetic 
susceptibility factor. Smoking plays a central role and over-
expression of TNF-α due to smoking may be important in 
producing emphysema and pulmonary ﬁ  brosis (Cottin et al 
2005; Lundblad et al 2005; Gauldie et al 2006).
Bronchogenic carcinoma associated 
with bullous lung disease
Bullous lung is a risk factor for bronchogenic carcinoma, 
with a 32 times higher risk of developing bronchogenic 
carcinoma in patients with BLD compared with those 
without BLD (Stoloff et al 1971). Radiological diagnosis 
Figure 25 Aging lung. Magniﬁ  ed photograph of a specimen showing slight enlarge-
ment of respiratory bronchioles and alveolar ducts. Clear destruction of the alveolar 
wall is not apparent.
Figure 26 Thickening of the bronchial wall in cases of pulmonary emphysema.
High resolution computed tomography showing thickening of the bronchial wall and 
narrowing of the lumen (arrows).
Figure 27 Combined pulmonary ﬁ  brosis and pulmonary emphysema (CPFE) in a 
59-year-old male who was a heavy smoker: High resolution computed tomography 
images.
In the upper lung ﬁ  eld (a), a prominent bullous change is apparent. In the middle lung 
ﬁ  eld (b), tiny air cysts (arrows) with ground-glass opacity are present in addition to 
the bullous changes.  In the lower lung ﬁ  eld (c), distributed tiny air cysts with deﬁ  n-
able walls and ground-glass opacity are apparent.  These features are consistent with 
interstitial ﬁ  brosis rather than pulmonary emphysema.International Journal of COPD 2008:3(2) 203
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of bronchogenic carcinoma is based on the shape, density, 
and interface with surrounding lung parenchyma. However, 
these morphologies in bronchogenic carcinoma can be 
changed by underlying emphysematous changes, including 
inﬂ  uences on the extent of the tumor and the tumor – lung 
interface. In the normal lung ﬁ  eld, bronchogenic carcinoma 
tends to grow globally, but this is not always true if the tumor 
occurs with pulmonary emphysema. Since tumors tend to 
grow along the intervening normal lung, bizarre shapes are 
often observed. Some cases have ﬁ  ndings that are similar 
to those of post-inﬂ  ammatory ﬁ  brotic changes because the 
tumor extends along the emphysematous lesion, resulting in 
a thickened band-like structure (Figure 28). Nodular form 
of the bronchiolar alveolar carcinoma has an ill-deﬁ  ned 
border because tumor cells in the periphery grow along the 
alveolar wall with preserving alveolar air space. However, 
the interface can be well deﬁ  ned if the dilated air space is 
neighboring to it. On CT, attention should be paid in the 
interpretation for mass or nodule in the wall of the bulla 
because they frequently lack the characteristic appearance 
of bronchogenic carcinoma.
Conclusion
HRCT plays an important role for analyzing pathologies 
of pulmonary emphysema not only in its morphological 
aspect but also in the assessment of severity. HRCT will 
also contribute the phenotyping of COPD, such as primarily 
parenchymal disease and primarily airway disease.
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